Home » Imperfect Harmony: Life Sciences Companies Must Partner to Thrive

Imperfect Harmony: Life Sciences Companies Must Partner to Thrive

Overview:

A just-released IBM study suggests that if life sciences companies do not collaborate, they risk delays in production. The survey, "An Imperfect Harmony: Alliances within the Life Sciences Industry," says that while the number of partnerships between larger and smaller life-sciences companies has increased over the past decade, the companies' abilities to effectively work together and produce new medicines has not been achieved.

Author: IBM

Find more white papers on cGMPs Compliance

View all white papers »

More content on this topic: